QSS
KITE

Quantitative Systematic Strategies’s Kite Pharma, Inc. KITE Stock Holding History

Quantitative Systematic Strategies’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,956
Closed -$613K – 532
2014
Q4 		$613K Buy
+10,956
New +$461K 0.25% 142

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Quantitative Systematic Strategies's KITE Position: Q1 2015 in Review

Quantitative Systematic Strategies sold out of Kite Pharma, Inc. (KITE) in Q1 2015, closing a stake of 10,956 shares — an estimated $613K sold.

Quantitative Systematic Strategies first reported a position in KITE in Q4 2014 and held it in 1 quarter. The position peaked at $613K in Q4 2014. 148 funds tracked by Wall St. Rank hold KITE as of Q1 2015.

  • Quantitative Systematic Strategies reported no remaining Kite Pharma, Inc. position as of Q1 2015 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 10,956 Kite Pharma, Inc. shares in Q1 2015, an estimated $613K.
  • Quantitative Systematic Strategies first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Kite Pharma, Inc. position peaked at $613K in Q4 2014.
  • 148 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2015.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2015, filed 9 Apr 2015.